Javascript must be enabled to continue!
Nota critica
View through CrossRef
Questa sezione spiega le divergenze rispetto all’edizione di riferimento (Davies, M.; Finglass, P.J. Stesichorus, The poems. Cambridge University Press, 2014) sotto tre diversi aspetti: la distinzione tra fragmenta e fragmenta incertae sedis; l’ordine dei fragmenta; singole scelte ecdotiche.
Fondazione Università Ca’ Foscari
Title: Nota critica
Description:
Questa sezione spiega le divergenze rispetto all’edizione di riferimento (Davies, M.
; Finglass, P.
J.
Stesichorus, The poems.
Cambridge University Press, 2014) sotto tre diversi aspetti: la distinzione tra fragmenta e fragmenta incertae sedis; l’ordine dei fragmenta; singole scelte ecdotiche.
Related Results
A Microdose Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Microdose Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, a nov...
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
Abstract
Background
The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic ac...
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, ...
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, ...
Dose Escalation Biodistribution, Positron Emission Tomography/Computed Tomography Imaging and Dosimetry of a Highly Specific Radionuclide-labeled Non-blocking Nanobody
Dose Escalation Biodistribution, Positron Emission Tomography/Computed Tomography Imaging and Dosimetry of a Highly Specific Radionuclide-labeled Non-blocking Nanobody
Abstract
Backgroud: Immunotherapy is a valuable option for the treatment of cancers, and the curative effect anti-PD-1/PD-L1 therapy correlates closely with PD-L1 expressio...
Predicting First Year University Students’ Academic Success
Predicting First Year University Students’ Academic Success
Introducción: El abandono universitario prematuro debido al fracaso académico puede resultar problemático para los estudiantes, las familias y los educadores. En un mayor esfuerzo ...
O smartphone na aprendizagem à luz da Teoria Histórico Crítica
O smartphone na aprendizagem à luz da Teoria Histórico Crítica
Este trabalho tem por objetivo principal refletir a utilização das tecnologias móveis na aprendizagem à luz da Teoria Histórico Critica. A metodologia a ser utilizada é a revisão l...
Dificuldades e estratégias na integração ao cuidado da pessoa em situação crítica: uma scoping review
Dificuldades e estratégias na integração ao cuidado da pessoa em situação crítica: uma scoping review
Introduction: The nurses’ integration in specialized care provision to critically ill patients is an increasing concern in the context of hiring and mobilizing nursing professional...

